Guardant Health
GH
#1569
Rank
โ‚ฌ11.36 B
Marketcap
87,52ย โ‚ฌ
Share price
-5.99%
Change (1 day)
154.25%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚ฌ1.09 Billion

According to Guardant Health 's latest financial reports the company's total assets are โ‚ฌ1.09 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Guardant Health - Total assets on balance sheet (from 2017 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚ฌ1.42 B-11.66%
2023-12-31โ‚ฌ1.61 B7.67%
2022-12-31โ‚ฌ1.50 B-22.89%
2021-12-31โ‚ฌ1.94 B5.39%
2020-12-31โ‚ฌ1.84 B114.96%
2019-12-31โ‚ฌ0.85 B67.34%
2018-12-31โ‚ฌ0.51 B79.65%
2017-12-31โ‚ฌ0.28 B157.91%
2016-12-31โ‚ฌ0.11 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Natera
NTRA
โ‚ฌ1.56 B 42.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
โ‚ฌ2.89 B 164.58%๐Ÿ‡บ๐Ÿ‡ธ USA